Recombinant Human C-C chemokine receptor type 8(CCR8) referenced in "The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis", Immunity, 2021.
Recombinant Human Novel Coronavirus Spike glycoprotein(S), partial (Active) referenced in "Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile", Science Advances, 2021.
Recombinant Human Novel Coronavirus Spike glycoprotein(S) (D614G), partial (Active) referenced in "Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries", Cell discovery, 2021.
Recombinant Human Aryl hydrocarbon receptor(AHR), partial referenced in "High throughput data-based, toxicity pathway-oriented development of a quantitative adverse outcome pathway network linking AHR activation to lung damages", Journal of Hazardous Materials, 2021.
Recombinant Human Angiotensin-converting enzyme 2(ACE2), partial (Active) referenced in "Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2", Cellular and molecular life sciences, 2021.
Recombinant Human Transmembrane protease serine 2(TMPRSS2), partial (Active) referenced in "Potent Anti-SARS-CoV-2 Activity by the Natural Product Gallinamide A and Analogues via Inhibition of Cathepsin L", Journal of medicinal chemistry, 2021.
Recombinant Mouse Alpha-(1,3)-fucosyltransferase 7(Fut7), partial referenced in "CD44 fucosylation on bone marrow-derived mesenchymal stem cells enhances homing and promotes enteric nervous system remodeling in diabetic mice", Cell & Bioscience, 2021.
